Literature DB >> 18359453

Incidence of deep vein thrombosis in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass.

Tomas Escalante-Tattersfield1, Olga Tucker, Patricio Fajnwaks, Samuel Szomstein, Raul J Rosenthal.   

Abstract

BACKGROUND: To define the incidence of deep vein thrombosis in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass.
METHODS: A retrospective study was conducted for all patients undergoing laparoscopic Roux-en-Y gastric bypass from 2004 to 2006. The data collected included patient demographics, body mass index, operative time, conversion rate, thromboprophylaxis measures, hospital stay, and complications.
RESULTS: Of the 618 patients included in the study, 451 (73%) were women and 167 (27%) were men, with a mean age of 44 years (range 18-78). The preoperative body mass index was 49 kg/m(2) (range 35-90). All patients received the same thromboprophylaxis regimen. All surgical procedures were performed and completed laparoscopically, with a mean operative time of 93 minutes (range 50-196). All patients underwent lower extremity color Doppler ultrasonography within the first 24 hours after the surgical procedure. The mean hospital stay was 4 days (range 2-21). The most common in-hospital complication was basal atelectasis in 52 patients (8.4%), followed by gastrointestinal bleeding in 10 (1.6%), and anastomotic leak in 6 (1%). The postoperative follow-up visits were done at 2, 8, 12, 24, and 52 weeks after surgery; no mortality occurred. The overall rate of deep vein thrombosis in the group of 500 consecutive patients was .2%, with no clinically significant pulmonary embolism; 9 patients presented with postoperative bleeding.
CONCLUSION: The overall rate of deep vein thrombosis in this group of patients was low, most probably because of the use of thromboprophylaxis.

Entities:  

Mesh:

Year:  2008        PMID: 18359453     DOI: 10.1016/j.soard.2007.12.015

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  18 in total

1.  The Effect of Obesity on Anti-Xa Concentrations in Bariatric Patients.

Authors:  W Schijns; M J Deenen; E O Aarts; J Homan; I M C Janssen; F J Berends; K A H Kaasjager
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

2.  Effect of adding intrathecal morphine to a multimodal analgesic regimen for postoperative pain management after laparoscopic bariatric surgery: a prospective, double-blind, randomized controlled trial.

Authors:  Fatma Adel El Sherif; Ahmed Hassan Othman; Ahmad Mohammad Abd El-Rahman; Osama Taha
Journal:  Br J Pain       Date:  2016-09-15

Review 3.  Prevention of venous thromboembolism in obesity.

Authors:  Andrew L Freeman; Robert C Pendleton; Matthew T Rondina
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-12

4.  Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery.

Authors:  Dino Kröll; Guido Stirnimann; Andreas Vogt; Desirée Lin Lee Lai; Yves Michael Borbély; Julia Altmeier; Sabine Schädelin; Daniel Candinas; Lorenzo Alberio; Philipp C Nett
Journal:  Br J Clin Pharmacol       Date:  2017-03-09       Impact factor: 4.335

5.  Magnesium Sulfate Reduced Opioid Consumption in Obese Patients Undergoing Sleeve Gastrectomy: a Prospective, Randomized Clinical Trial.

Authors:  Nurcan Kizilcik; Ozge Koner
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

Review 6.  Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review.

Authors:  Gregory Egan; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2015 Jan-Feb

7.  Adding chemoprophylaxis to sequential compression might not reduce risk of venous thromboembolism in bariatric surgery patients.

Authors:  Michel Gagner; Faith Selzer; Steve H Belle; Marc Bessler; Anita P Courcoulas; Gregory F Dakin; Dan Davis; William B Inabnet; James E Mitchell; Alfons Pomp; Gladys W Strain; Walter J Pories; Bruce M Wolfe
Journal:  Surg Obes Relat Dis       Date:  2012-07-31       Impact factor: 4.734

8.  Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry.

Authors:  Randall R De Martino; Adam W Beck; Matthew S Edwards; Matthew A Corriere; Jessica B Wallaert; David H Stone; Jack L Cronenwett; Philip P Goodney
Journal:  J Vasc Surg       Date:  2012-07-24       Impact factor: 4.268

9.  Pulmonary embolism and deep venous thrombosis following bariatric surgery.

Authors:  Paul D Stein; Fadi Matta
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

10.  The impact of surgical complications as a main risk factor for venous thromboembolism: a multicenter study.

Authors:  F Celik; F Bounif; J M Fliers; B E Kersten; F M H van Dielen; H A Cense; D P M Brandjes; B A van Wagensveld; I M C Janssen; A W J M van de Laar; V E A Gerdes
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.